tiprankstipranks
Trending News
More News >
Definium Therapeutics (DFTX)
NASDAQ:DFTX

Compare Definium Therapeutics (DFTX) vs. Competitors

Compare
2,146 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Definium Therapeutics
$15.05
$1.48B
-7.63
131.18%
10 Buy
0 Hold
0 Sell
Strong Buy
AnaptysBio
$45.68
$1.26B
-16.20
203.93%
9 Buy
1 Hold
0 Sell
Strong Buy
Enliven Therapeutics
$26.71
$1.59B
-14.47
21.46%
6 Buy
0 Hold
0 Sell
Strong Buy
Tyra Bioscience
$28.77
$1.54B
-15.31
78.14%
5 Buy
0 Hold
0 Sell
Strong Buy
Biohaven Ltd.
$13.14
$1.91B
-63.35%
8 Buy
6 Hold
0 Sell
Moderate Buy
Inhibrx Biosciences Inc
$85.32
$1.05B
-7.06
433.75%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DFTX
Definium Therapeutics
15.05
7.87
109.61%
ANAB
AnaptysBio
45.68
28.80
170.62%
ELVN
Enliven Therapeutics
26.71
4.71
21.41%
TYRA
Tyra Bioscience
28.77
12.86
80.83%
BHVN
Biohaven Ltd.
13.14
-25.89
-66.33%
INBX
Inhibrx Biosciences Inc
72.27
58.08
409.30%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts